Independence is maintained by keeping the resource separate from clinical, treatment, and legal claims.
Title block / 01.00
About
Synapse Mason is an independent resource on neuroplasticity, psychedelics, evidence, and safety.
100 × 100 / reference field
01 / Purpose
A resource built for careful comparison.
Synapse Mason exists to support careful comparison of mechanisms, evidence, risks, ethics, and regulatory change. It is an independent reference about ibogaine and classical psychedelics for neuroplasticity, designed for readers who want context without hype.
The site is organized to make questions easier to locate and claims easier to inspect. The main comparison framework establishes the subject area, while our site guidance describes the kinds of material readers can use to orient their own questions.
We do not present a treatment pathway or a substitute for professional judgment. People looking at difficult, high-stakes decisions can also find focused context on fentanyl-related considerations and stimulant-related questions in the wider resource landscape.
02 / Method
Our editorial approach.
Synapse Mason works from published literature, trial registries, official sources, and clearly identified research limits. Trial records are useful for checking what is being studied and how, including through the ClinicalTrials.gov study registry.
Claims are framed by the strength and limits of the available material. We distinguish early findings, established knowledge, interpretation, and questions that remain unresolved. This approach reflects the importance of transparent methods and reproducibility described by the National Academies’ work on reproducibility.
Where readers need issue-specific context, we point toward discussions of trauma-related context and relapse-related decision points without presenting either as individual guidance.
03 / Principles
The working rules behind the resource.
Evidence comes before hype: sources, scope, and uncertainty matter as much as conclusions.
Plain language is used to make complex material more navigable without pretending it is simple.
Safety awareness belongs beside any discussion of potential benefit, especially where stakes are personal.
04 / Scope
What we cover, and what we do not provide.
| Coverage | Mechanisms, evidence, safety, ethics, and regulatory change, organized for patients, families, researchers, and policy-minded readers. |
|---|---|
| Source practice | Published literature, registries, and official sources are checked against the limits of what each source can support. |
| Reader context | Relevant external context can include abstinence-related framing, the role of supervision, and magnesium-related considerations. |
| Boundary | Synapse Mason does not diagnose, recommend treatment, provide legal interpretation, or direct individual medical decisions. |
05 / Readers
For people looking for careful context.
This resource is for patients, families, researchers, and policy-minded people seeking careful context on psychedelic neuroplasticity. It is designed to support better questions, not to provide individual answers.
Some readers arrive with personal concerns; others are mapping a research or policy question. Material on ego and subjective experience may be relevant to those conversations, but it remains informational rather than prescriptive.
- Patients and families who need a clearer map of the questions.
- Researchers who value explicit source boundaries and research limits.
- Policy-minded readers tracking evidence, ethics, and regulatory change.
Status / Independent by design
Independent information, clearly bounded.
Synapse Mason is an independent information resource, not a clinic, medical provider, or licensed treatment center. Its content is not medical or legal advice. For questions about the boundaries of this resource, use the available contact route.